Juan Andres
Director/Board Member chez AVANTOR, INC.
Fortune : 1 M $ au 31/03/2024
Postes actifs de Juan Andres
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVANTOR, INC. | Director/Board Member | 01/09/2019 | - |
| Independent Dir/Board Member | 01/09/2019 | - | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Historique de carrière de Juan Andres
Anciens postes connus de Juan Andres
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EVELO BIOSCIENCES, INC. | Director/Board Member | 04/12/2019 | 20/11/2023 |
| Independent Dir/Board Member | 04/12/2019 | 20/11/2023 | |
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01/08/2017 | 01/01/2023 |
| Corporate Officer/Principal | 01/01/2023 | 31/05/2023 | |
| NOVARTIS AG | Chief Tech/Sci/R&D Officer | 01/08/2005 | 01/06/2017 |
| Corporate Officer/Principal | - | - | |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/1987 | 01/01/2009 |
Formation de Juan Andres
| Universida de Alcalá de Henares | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Suisse | 2 |
| Espagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 2 |
| Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NOVARTIS AG | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| AVANTOR, INC. | Process Industries |
| MODERNA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Juan Andres
- Expérience
